Terug
82
Dagbereik
€ 1,85
€ 1,94
52-Weeksbereik
€ 1,85
€ 3,92
Volume
4.657.086
50D / 200D Gem.
€ 2,19
/
€ 2,65
Vorige Slotkoers
€ 1,89
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -11,1 | 0,4 |
| P/B | 3,1 | 2,9 |
| ROE % | -26,3 | 3,7 |
| Net Margin % | -4,5 | 3,9 |
| Rev Growth 5Y % | 6,9 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 3,00
+62.2%
Forward K/W
43,2
Forward WPA
€ 0,04
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,9 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,28
€ 0,28 – € 0,28
|
4,8 B | 1 |
| FY2029 |
€ 0,21
€ 0,21 – € 0,21
|
4,3 B | 1 |
| FY2028 |
€ 0,12
€ 0,06 – € 0,18
|
3,7 B | 2 |
Belangrijkste Punten
Revenue grew 6,93% annually over 5 years — modest growth
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -68,98M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 33,41%
Capital efficient — spends only 0,11% of revenue on capex
Groei
Revenue Growth (5Y)
6,93%
Revenue (1Y)40,34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-26,33%
ROIC-20,78%
Net Margin-4,45%
Op. Margin-4,44%
Veiligheid
Debt / Equity
0,00
Current Ratio1,47
Interest Coverage0,00
Waardering
P/E Ratio
-11,07
P/B Ratio3,07
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 40,34% | Revenue Growth (3Y) | 23,55% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 6,93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,92B | Net Income (TTM) | -85,55M |
| ROE | -26,33% | ROA | -15,81% |
| Gross Margin | 18,49% | Operating Margin | -4,44% |
| Net Margin | -4,45% | Free Cash Flow (TTM) | -68,98M |
| ROIC | -20,78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 1,47 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,07 | P/B Ratio | 3,07 |
| P/S Ratio | 0,49 | PEG Ratio | -0,15 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 947,16M | Enterprise Value | 868,86M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,92B | 1,37B | 1,26B | 1,10B | 1,47B |
| Net Income | -85,55M | -43,01M | -213,36M | -339,57M | -587,76M |
| EPS (Diluted) | -0,17 | -0,09 | -0,45 | -0,71 | -1,25 |
| Gross Profit | 355,88M | 364,80M | 255,95M | 103,48M | -79,18M |
| Operating Income | -85,53M | -45,75M | -205,33M | -286,66M | -636,99M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 541,01M | 580,74M | 570,67M | 808,62M | 950,80M |
| Total Liabilities | 232,31M | 239,60M | 284,28M | 451,73M | 411,49M |
| Shareholders' Equity | 308,70M | 341,14M | 286,39M | 356,89M | 535,41M |
| Total Debt | 0,0 | 0,0 | 4,66M | 5,86M | 27,83M |
| Cash & Equivalents | 78,30M | 194,54M | 116,41M | 103,79M | 299,97M |
| Current Assets | 307,86M | 343,12M | 427,97M | 625,00M | 752,55M |
| Current Liabilities | 208,82M | 213,52M | 261,12M | 431,51M | 372,62M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#35 of 616
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026